Navigation Links
Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
Date:2/24/2011

THOUSAND OAKS, Calif., Feb. 24, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced the publication of results from a Phase 3 head-to-head trial that compared XGEVA (denosumab) to Zometa® (zoledronic acid) in preventing bone complications called skeletal-related events (SREs) in 1,901 men with prostate cancer and bone metastases. The study, published in The Lancet, met its primary and secondary endpoints and demonstrated XGEVA's superiority compared to Zometa in preventing SREs.

XGEVA was approved by the U.S. Food and Drug Administration (FDA) on Nov. 18, 2010 for the prevention of SREs in patients with bone metastases from solid tumors, including prostate cancer.  XGEVA is not indicated for the prevention of SREs in patients with multiple myeloma.  XGEVA, the first and only FDA-approved RANK Ligand inhibitor, is the first new treatment for advanced cancer patients with bone metastases in nearly a decade.  

"Bone metastases represent a significant risk for advanced prostate cancer patients due to the potential for serious bone complications such as fracture and spinal cord compression," said Karim Fizazi, M.D., Ph.D., head of the department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. "The results of this study show that XGEVA prevents these serious bone complications more effectively than Zometa without the requirement of intravenous infusion and without the need for dose adjustment for renal function.  XGEVA represents an important new treatment option for advanced prostate cancer patients with bone metastases."

Bone metastases, the spread of cancer to the bones, are a serious concern for patients with advanced cancer and present a considerable burden to the healthcare system. Weakened bones due to metastases can lead to fractures and compression of the spinal cord and necessi
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015  Bayer HealthCare today announced that ... accepted the company,s Biologics License Application (BLA) for ... is seeking FDA approval of the investigational compound, ... hemophilia A in children and adults. ... therapies to hemophilia A patients who need them," ...
(Date:3/4/2015)... Colo. , March 4, 2015  Heska Corporation ... What:Heska Corporation Invites You to Join Its Fourth Quarter ... WebWhen:Thursday, March 5, 2015 @ 9:00 a.m. (MST) / ... and Year End 2014 Earnings Call link on the ... Simply log on to the web at the address ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4f69k2/negative_pressure ) ... Pressure Wound Therapy Market (Conventional and Single Use ... Growth, Trends and Forecast 2014 - 2020" ... The global negative pressure wound therapy market is ... product types the NPWT market is segmented into ...
Breaking Medicine Technology:FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2
... China, April 13, 2012 /PRNewswire-Asia/ -- At the invitation ... of Sichuan University, Mr.Vishnu Chaturvedi, the expert from the New York ... Medical College, USA, and also the Editor in Chief ... lecture to the faculty and the students of the ...
... that they have received FDA clearance to market the ... i-Lipo is the first direct skin contact laser ... receive FDA clearance for circumferential reduction. Based on results ... volunteers, the FDA found that over 70% of participants ...
Cached Medicine Technology:Chromogenex Receives FDA Clearance for Circumferential Reduction for i-Lipo Body Contouring System 2Chromogenex Receives FDA Clearance for Circumferential Reduction for i-Lipo Body Contouring System 3
(Date:3/4/2015)... 2015 TROY Healthcare Solutions will be ... the ultimate level of security for prescriptions, in Houston, ... Plaza Medical Center located at 6633 Travis Street from ... 7 AM, TROY Healthcare Solutions will host a continental ... offer brief presentations each hour to introduce attendees to ...
(Date:3/4/2015)... York, NY (PRWEB) March 04, 2015 ... creative, breakthrough marketing campaign called 'We Love Smokers' from ... cravings for tobacco. , "It’s important to establish ... be true to it. Our idea, 'We Love Smokers' ... leadership point of view. We created a bold tone ...
(Date:3/4/2015)... 2015 Starting February 2015, Dr. Joseph ... procedures at their new location in Surrey. , In ... and Dr. Gabriel Chu also provide comprehensive ophthalmology services, ... named Fraser Valley Cataract and Laser (FVCL). This state ... College of Physicians and Surgeons of British Columbia. Fraser ...
(Date:3/4/2015)... 2015 " Optrix by Body Glove ... monthly Tech Report, which takes a look at the ... consumers. Scott Steinberg, a special reporter for NewsWatch and ... with viewers how they have an ultra-rugged, waterproof case ... is a major player at the Consumer Electronics Show ...
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:King LASIK relocates to Surrey, British Columbia 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2
... 2011) - Proposals recommending routine screening of all children ... University. In a study in the online edition of ... "not enough sound evidence to support the implementation of a ... there no good screening tools or effective treatments but there ...
... (HealthDay News) -- Heart attack patients whose ambulances are diverted ... at greater risk of dying -- not just soon after ... the intervention, a new study finds. Researchers examined data ... for heart attack at hospitals in four California counties (Los ...
... 35% of anaesthesiologists are carrying out a simple procedure ... on how well patients recover from their operations, according ... the European Anaesthesiology Congress in Amsterdam. A survey ... that although more than 95% of them knew that ...
... Alan Mozes HealthDay Reporter , FRIDAY, June 10 ... departments for non-urgent primary care are a big source of ... a new national survey reveals. Roughly 90 percent of ... resources and staff to manage chronic medical and social issues ...
... who visited a VA integrated care clinic were much ... work evaluations than veterans who visited a standard VA ... a San Francisco VA Medical Center researcher. The ... veterans with mental health diagnoses, and veterans who screened ...
... medicine and director of the rheumatology division at ... colleagues from the medical center for rheumatoid arthritis ... the blogosphere to discuss advances in the investigation, ... be viewed at: , http://coe.musculoskeletaldisease.webdev.nyumc.org/research/whats-up-with-ra-webinar "Although ...
Cached Medicine News:Health News:Routine screening for autism not needed: McMaster researchers 2Health News:Heart Attack Victims Face Greater Risk of Dying When Ambulances Are Diverted 2Health News:Heart Attack Victims Face Greater Risk of Dying When Ambulances Are Diverted 3Health News:Important monitoring of heart performance is omitted in two-thirds of high-risk surgical operations 2Health News:Important monitoring of heart performance is omitted in two-thirds of high-risk surgical operations 3Health News:ER Docs Frustrated, Burned Out by Repeat Patients: Survey 2Health News:ER Docs Frustrated, Burned Out by Repeat Patients: Survey 3Health News:'1-stop' clinic ups mental health, social work visits for veterans 2Health News:'1-stop' clinic ups mental health, social work visits for veterans 3Health News:NYU Langone rheumatologists share insight with online RA community 2
... The Surgifoam* absorbable gelatin sponge, U.S.P. ... gelatin absorbable sponge intended for hemostatic ... surface. The sponge is off-white and ... speed to hemostasis, highly favorable surgeon ...
12 mm diameter pigtail curved probes with eyes 4mm back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.9 inches....
The Meridian Microruptor V Nd: YAG laser system is indicated for posterior capsulotomy, peripheral iridotomy, and pupillary membranectomy procedures....
... for determining color vision abnormalities and testing ... be applied to many psychological and industrial ... four trays containing a total of 85 ... hue variation on one side and are ...
Medicine Products: